These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 542584)

  • 1. Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload.
    Gokal R; Millard PR; Weatherall DJ; Callender ST; Ledingham JG; Oliver DO
    Q J Med; 1979 Jul; 48(191):369-91. PubMed ID: 542584
    [No Abstract]   [Full Text] [Related]  

  • 2. Hematologic parameters and iron stores in patients on hemodialysis for chronic renal failure.
    Nuwayri-Salti N; Jabre F; Daouk M; Sa'ab G; Salem Z
    Clin Nephrol; 1992 Aug; 38(2):101-4. PubMed ID: 1516277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ferritin concentration: a reliable guide to iron overload in uremic and hemodialyzed patients.
    Aljama P; Ward MK; Pierides AM; Eastham EJ; Ellis HA; Feest TG; Conceicao S; Kerr DN
    Clin Nephrol; 1978 Sep; 10(3):101-4. PubMed ID: 699405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: Ferritinaemia and iron status in haemodialysis patients.
    Hussein S; Prieto J; O'Shea M
    Br J Haematol; 1974 Jun; 27(2):360. PubMed ID: 4843682
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum ferritin and iron deficiency in patients on chronic hemodialysis.
    Beallo R; Dallman PR; Schoenfeld PY; Humphreys MH
    Trans Am Soc Artif Intern Organs; 1976; 22():73-9. PubMed ID: 951893
    [No Abstract]   [Full Text] [Related]  

  • 6. [Etiology, diagnosis and therapy of iron deficiency].
    Heinrich HC
    Haematol Blood Transfus; 1978; 21():35-94. PubMed ID: 367900
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of iron therapy in patients in long-term haemodialysis (author's transl)].
    Serra A; Morlans M; Olmos A; Camps J; Rodríguez JA; Carreras A; Soriano B; Bartolomé J; Piera L
    Med Clin (Barc); 1982 Apr; 78(8):313-7. PubMed ID: 7087599
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Iron reserves in patients with chronic renal insufficiency].
    Shostka GD
    Ter Arkh; 1987; 59(8):97-102. PubMed ID: 3686452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Iron therapy in patients in the chronic intermittent hemodialysis program (CHIHP)].
    Chrobák L; Radochová D; Erben J; Strnad L; Rouchal J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1981; 24(2):173-91. PubMed ID: 6975987
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined studies of iron metabolism and hematologic examination of patients with chronic renal failure].
    Indulska M
    Pol Tyg Lek; 1974 Dec; 29(52):2245-8. PubMed ID: 4445043
    [No Abstract]   [Full Text] [Related]  

  • 12. [The iron reserve status in patients on regular dialysis treatment].
    Zadrazil J; Papajík T; Scudla V; Jezáková J; Budíková M; Slavícek J
    Vnitr Lek; 1991 Apr; 37(4):369-75. PubMed ID: 2053308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iron metabolism in chronic renal failure (author's transl)].
    Tabernero Romo JM; Rodríguez Commes JL; Macías Núñez JF; Corbacho Becerra L; Bondía Román A; Sánchez Martín S; Juanes A; Talavera JR; De Castro S
    Sangre (Barc); 1980; 25(5B):657-64. PubMed ID: 7466549
    [No Abstract]   [Full Text] [Related]  

  • 14. Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy.
    Ali M; Rigolosi R; Fayemi AO; Braun EV; Frascino J; Singer R
    Lancet; 1982 Mar; 1(8273):652-5. PubMed ID: 6121967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed therapeutic algorithm for the treatment of anemia of chronic renal failure in pre-dialysis patients with low dose once weekly subcutaneous r-HuEPO. Multicenter Study Group, Israel.
    Yagil Y
    Isr J Med Sci; 1997 Jan; 33(1):36-44. PubMed ID: 9203516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Response to 2 methods of parenteral administration of iron in patients in periodical hemodialysis].
    Miguel Carrasco JA; Alcocer Ferrer H; Caridad Monforte A; Lozano Roig L; Giner Segui R; Caparros Puchalt J; Rosalen Archer R
    Rev Clin Esp; 1979 Apr; 153(2):117-20. PubMed ID: 482675
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of anemia in patients with terminal renal insufficiency in haemodialysis. Working hypothesis and preliminary results (author's transl)].
    Escribano Mora L; Sanz Guajarado A; García de Bustos JM; Sánchez Sicilia L; Torre Carballada A; Martínez Ara J; Gómez Fernández P; Selgas Guítierrez R; Martín Villar J
    Sangre (Barc); 1980; 25(5B):688-96. PubMed ID: 7466551
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of haemodialysis-associated anaemia by deferoxamine. Effects on serum aluminum and iron overload.
    von Bonsdorff M; Sipilä R; Pitkänen E
    Scand J Urol Nephrol Suppl; 1990; 131():49-54. PubMed ID: 2075470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron stores in adults with sickle cell anemia.
    Rao KR; Patel AR; McGinnis P; Patel MK
    J Lab Clin Med; 1984 May; 103(5):792-7. PubMed ID: 6715957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.